Order results by:
| Issue | Title | |
| Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
| "... of using the last generation of calcium channel blockers in this clinical situation with an emphasis ..." | ||
| Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
| "... Classification, modes of action and clinical effects of calcium channel blockers are presented ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials ..." | ||
| Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
| E. I. Emelina, G. E. Gendlin | ||
| "... Features and possibility of application of the calcium channel blocker lercanidipine in cardiology ..." | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... and safety of the combination of calcium antagonist of the third generation, lercanidipine, and ACE inhibitor ..." | ||
| Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
| A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
| "... for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... lercanidipine and angiotensin-converting enzyme inhibitor enalapril. ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... Цель. Оценить эффективность лерканидипина (антагониста кальция из группы дигидропиридинов) у ..." | ||
| Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
| E. EL. Trisvetova | ||
| "... . Lercanidipine is a dihydropyridine calcium channel blocker of the third generation with high lipophilicity ..." | ||
| Vol 10, No 3 (2014) | OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE | Abstract similar documents |
| E. L. Trisvetova | ||
| "... to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine ..." | ||
| Vol 12, No 6 (2016) | RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME | Abstract similar documents |
| O. M. Drapkina, J. S. Sibgatullina | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker ..." | ||
| Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
| I. M. Sokolov | ||
| "... medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel ..." | ||
| Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
| M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..." | ||
| Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
| O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... препаратов наибольшим потенциалом в снижении вариабельности обладают антагонисты кальция, главным образом ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
| S. A. Boitsov, R. M. Linchak | ||
| "... гипертонией. Особое внимание уделяется применению комбинации ингибитора АПФ с антагонистами кальция. ..." | ||
| Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... Aim. To study the effect of olmesartan/lercanidipine combination and zofenopril/lercanidipine ..." | ||
| Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
| "... are presented. The advantages of ACE inhibitor+calcium channel blocker combination are shown in terms ..." | ||
| Vol 3, No 2 (2007) | CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS | Abstract similar documents |
| D. V. Nebieridze | ||
| "... . Антагонисты кальция являются одним из самых эффективных классов препаратов в плане вазопротекции. Нами ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented ..." | ||
| Vol 20, No 3 (2024) | BRASH syndrome: а clinical case | Abstract similar documents |
| D. D. Shalaeva, K. G. Pereverzeva, O. A. Fomina, S. S. Yakushin | ||
| "... , lercanidipine hydrochloride daily. She was admitted to the hospital complaining of weakness, eyes darkening ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| "... Рассматриваются результаты рандомизированных клинических исследований по применению антагонистов ..." | ||
| Vol 2, No 4 (2006) | CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY | Abstract similar documents |
| R. I. Striuk | ||
| "... незамедлительно. Антагонисты кальция (АК) из группы дигидропиридинов являются препаратами выбора для лечения АГ у ..." | ||
| Vol 4, No 2 (2008) | FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva | ||
| "... Статья посвящена применению антагонистов кальция (АК) при артериальной гипертонии (АГ) с позиций ..." | ||
| Vol 7, No 3 (2011) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE | Abstract similar documents |
| A. A. Garganeeva | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS | Abstract similar documents |
| Y. A. Karpov, V. V. Buza | ||
| "... изолированной систолической АГ. Обосновываются преимущества дигидропиридиновых антагонистов кальция (ДПАК) в ..." | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... Приводится классификация антагонистов кальция (АК). Анализируются результаты крупных исследований ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..." | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
| Z M. Sizova | ||
| "... Current possibilities of AT1 receptor blockers (ARBs), such as candesartan, for optimization ..." | ||
| Vol 6, No 3 (2010) | EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| D. A. Yakhontov, N. F. Balabanova | ||
| "... антагонистов кальция. Результаты. Амлодипин в составе комплексной терапии показал высокую антигипертензивную ..." | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... -Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... Приводится классификация антагонистов кальция. Рассматриваются результаты крупных ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| "... conditions is studied well. The key role of aldosterone receptor blockers, particularly spironolactone ..." | ||
| Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
| O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
| "... daily). Basic therapy included anticoagulants, antiplatelets, beta-blockers, nitrates and statins ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..." | ||
| Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
| O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
| "... (indapamide) and dihydropyridine calcium channel blocker (amlodipine) on ambulatory blood pressure (BP ..." | ||
| Vol 13, No 4 (2017) | PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY | Abstract similar documents |
| O. M. Drapkina, D. U. Akasheva | ||
| "... -converting enzyme inhibitors and beta-blockers, are neurohumoral modulators. They are used to treat patients ..." | ||
| Vol 6, No 2 (2010) | RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and dihydropyridine calcium channel blocker (DCCB), on frequency of cardiovascular events is studied in many trails ..." | ||
| Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... channel blocker is one of the most efficient, since both groups of drugs act as vasodilators and have ..." | ||
| Vol 17, No 2 (2021) | Treatment of Resistant Hypertension in Real Clinical Settings | Abstract similar documents |
| A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin | ||
| "... ] blocker + calcium-channel blocker [CCB] + diuretic) plus one of the group of reserve drugs ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... in patients with stable angina significantly increased: antiplatelets – up to 82.7%, beta-blockers – up to 74 ..." | ||
| Vol 7, No 2 (2011) | CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE | Abstract similar documents |
| M. V. Leonova | ||
| "... Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its ..." | ||
| Vol 12, No 3 (2016) | PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky | ||
| "... Aim. To assess real clinical practice of prescribing beta-blockers (BB) and its compliance ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... ,4%) patients received ACE inhibitors, 435 (55%) patients - beta-blockers, 230 (29,1%) patients - calcium ..." | ||
| Vol 4, No 3 (2008) | ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence ..." | ||
| Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
| "... Aim. To study effects of calcium channel blocker, amlodipine on indices of ambulatory blood ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... ; it is known that some angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers ..." | ||
| Vol 16, No 4 (2020) | Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist | Abstract similar documents |
| M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya | ||
| "... combinations today contain a renin-angiotensin system blocker (angiotensin converting enzyme inhibitors ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... declined from 44.4% in 2011-12 to 37.2% in 2013-14 (р<0.05). Angiotensin receptor blockers partially ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... -blockers, the use of beta-adenoblocker with vasodilating activity, in particular carvedilol, makes ..." | ||
| Vol 11, No 2 (2015) | ALCOHOL-INDUCED CARDIAC RHYTHM DISORDERS IN PATIENTS WITH ALCOHOL DEPENDENCE: TYPES OF ARRHYTHMIAS, MECHANISMS OF ORIGIN, PARTICULARITIES OF COURSE AND ANTIARRHYTHMIC THERAPY | Abstract similar documents |
| A. S. Aksel'rod, A. L. Syrkin | ||
| "... supraventricular arrhythmias - only in 16.2% of cases. Beta-blockers, as well as combination of beta-blocker ..." | ||
| Vol 12, No 1 (2016) | Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) | Abstract PDF (Eng) similar documents |
| E. L. Trisvetova, S. V. Gubkin | ||
| "... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| Vol 4, No 2 (2008) | BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL | Abstract similar documents |
| A. N. Zakirova, F. S. Zarudij, B. N. Garifullin | ||
| "... Approaches evolution to studying of beta-blockers influence on platelet aggregation is reviewed ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
| M. Tamirci, R. Demirdamar | ||
| "... of antihypertensive agents per prescription was 1.2±0.6. According to the ATC-3 subclassification, beta-blockers (22 ..." | ||
| Vol 2, No 2 (2006) | PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING | Abstract similar documents |
| N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich | ||
| "... %, beta-blockers – 28%, diuretics – 26% and calcium antagonists – 10%. Other classes of antihypertensive ..." | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... and amlodipine, as the reference drug of angiotensin II receptor blockers and calcium channel blockers ..." | ||
| Vol 4, No 5 (2008) | EFFECT OF AMLODIPINE AND OF NIFEDIPINE RETARD ON AUTONOMIC REGULATION OF HEART RATE IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. D. Golovanova, T. V. Osipova | ||
| "... Aim. To study the effect of the monotherapy with calcium channel blockers (amlodipine, 5 mg/d ..." | ||
| Vol 15, No 5 (2019) | Modern Principles of Treatment of Uncontrolled Hypertension | Abstract similar documents |
| V. I. Podzolkov, A. I Tarzimanova, Z. O. Georgadze | ||
| "... of arterial hypertension in 2018, remain a combination of blockers of the renin-angiotensin-aldosterone system ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
| "... converting enzyme inhibitor and β-blocker in patients with arterial hypertension (AH) taking into account ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... and various beta-blockers (atenolol, metoprolol, bisoprolol). These beta-blockers were changed for carvedilol ..." | ||
| Vol 15, No 6 (2019) | Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov | ||
| "... single-pill combinations is the combination of an angiotensin II receptor blocker and a calcium channel ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... lower than ACE inhibitors. Bisoprolol was most common beta-blocker. Calcium antagonists: if amlodipine ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... -angiotensin-aldosterone system (RAAS) blockers, indapamide and calcium channel blocker (CCB) in hypertensive ..." | ||
| Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
| O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
| "... (in different regions). Patients received ACE inhibitors in 50-54% of cases, angiotensin receptor blockers ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... Необходимо тщательно контролировать состояние коагуляции на фоне приема антагонистов витамина К ..." | ||
| Vol 8, No 6 (2012) | TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE | Abstract similar documents |
| O. D. Ostroumova, G. N. Shchukina, V. M. Fomina | ||
| Vol 5, No 4 (2009) | METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER | Abstract similar documents |
| B. N. Garifullin, A. N. Zakirova, F. S. Zarudij | ||
| "... Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI ..." | ||
| Vol 7, No 2 (2011) | SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... -blockers among all available drugs for SCD prevention. ..." | ||
| Vol 13, No 6 (2017) | THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| A. N. Zakirova, B. N. Garifullin, N. E. Zakirova | ||
| "... in experimental data. Carvedilol is a third-generation beta-blocker with additional pleiotropic and antioxidant ..." | ||
| Vol 6, No 6 (2010) | THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS | Abstract similar documents |
| Yu. A. Bunin | ||
| "... and VA only beta-blockers and amiodarone are able to reduce mortality, while other drugs have no effect ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts ..." | ||
| Vol 6, No 5 (2010) | WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov | ||
| "... Aim. To determine indications for differential prescription of beta-blockers in patients ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... . To evaluate the efficacy and safety of beta-blocker bisoprolol in the perioperative period in hypertensive ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays ..." | ||
| Vol 9, No 5 (2013) | THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS? | Abstract similar documents |
| A. N. Sumin | ||
| "... the available scientific evidence. In this review we discussed in detail the use of beta-blockers in noncardiac ..." | ||
| Vol 10, No 6 (2014) | IRBESARTAN IN THE CLINICAL PRACTICE | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 8, No 2 (2012) | TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..." | ||
| Vol 4, No 5 (2008) | CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... for comparable study of efficacy and safety of therapies based on β-blockers (carvedilol and metoprolol ..." | ||
| Vol 16, No 3 (2020) | The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril | Abstract similar documents |
| A. I. Kochetkov, S. V. Batyukina, O. D. Ostroumova, M. Yu. Nazranova, V. N. Butorov | ||
| "... of an angiotensin converting enzyme inhibitor and a calcium channel blocker. The reference drugs in both classes due ..." | ||
| Vol 16, No 5 (2020) | Untapped Possibilities of Antiischemic Therapy after Acute Myocardial Infarction: Data from the PROFILE-IM Register | Abstract similar documents |
| E. P. Kalaydzhyan, S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, O. M. Drapkina | ||
| "... dispensary supervision. Almost all patients received beta-blockers (97.4%), about a third of patients ..." | ||
| Vol 12, No 1 (2016) | The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev | ||
| "... (RR=1.6), atrial fibrillation (RR=1.4). Patients who were treated with calcium channel blockers before ..." | ||
| Vol 11, No 2 (2015) | A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE | Abstract similar documents |
| B. B. Gegenava, O. M. Drapkina | ||
| "... селективного антагониста минералокортикоидных рецепторов эпле-ренона. Обсуждаются преимущества эплеренона в ..." | ||
| Vol 20, No 1 (2024) | Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study | Abstract similar documents |
| Yu. A. Balanova, S. A. Shalnova, V. A. Kutsenko, A. E. Imaeva, O. E. Ivlev, S. E. Evstifeeva, A. V. Kapustina, M. B. Kotova, S. A. Maksimov, G. A. Muromtseva, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, O. A. Bashkina, S. V. Glukhovskaya, I. A. Levina, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovieva, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, E, V. Mikhailov, Yu. O. Tarabrina, M. G. Ataev, M. O. Radzhabov, Z. M. Gasanova, M. A. Umetov, I. A. Hakuasheva, i. V. Elgarova, E. I. Yamashkina, L. А. Balykova, A. A. Usanova, A. M. Nikitina, N. V. Savvina, Iu. E. Spiridonova, E. A. Naumova, V. S. Yudin, A. A. Keskinov, S. M. Yudin, A. V. Kontsevaya, O. M. Drapkina | ||
| "... inhibitors (ACEIs) were used by 38.8% of participants, angiotensin receptor blockers (ARBs) — 31 ..." | ||
| Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
| A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
| "... . A positive result of treatment depends on the severity of long QT syndrome and its genotype. Beta-blockers ..." | ||
| Vol 8, No 5 (2012) | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN | Abstract similar documents |
| R. I. Striuk, Ya. V. Brytkova | ||
| Vol 4, No 5 (2008) | INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS | Abstract similar documents |
| V. V. Fomin | ||
| "... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..." | ||
| Vol 15, No 5 (2019) | Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris | Abstract similar documents |
| V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova | ||
| "... Aim. To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB ..." | ||
| Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
| V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
| "... of the combination of thiazide-like diuretic with calcium channel blocker in the morning and ACE inhibitor in bedtime ..." | ||
| 1 - 100 of 336 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
